Explore comprehensive CDMO services offered by Pluri Inc, supporting end-to-end Analaytical Testing, Clinical Studies, Cosmetics Development, Drug Development, Manufacturing and Packaging. Pluri Inc enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Israel
Description: Pluri is a global CDMO focused on cell therapy manufacturing and process development. Since 2003, the company has advanced therapeutics through preclinical to Phase III clinical development, with over two decades of experience in cell expansion, process scale-up, and analytical development.
